Bacteriophages, or phages, are viruses that specifically infect bacteria and coopt the cellular
machinery to create more phage proteins, eventually resulting in the release of new phage …

Clinical progress in the field of HER2-positive breast cancer therapy has been dramatically
improved by understanding of the immune regulatory mechanisms of tumor …

Phage display is a nanotechnology with limitless potential, first developed in 1985 and still
awaiting to reach its peak. Awarded in 2018 with the Nobel Prize for Chemistry, the method …

Breast cancer is the second most common kind of cancer worldwide and oncolytic viruses
may offer a new treatment approach. There are three different types of oncolytic viruses used …

Immunotherapy is a major emerging treatment for breast cancer (BC). However, not all
breast cancer patients derive benefit from immunotherapy. Predictive biomarkers of …

Intestinal microbiota plays a key role in regulating the pathogenesis of human disease and
maintaining health. Many diseases, mainly induced by bacteria, are on the rise due to the …

Introduction Breast carcinoma (BC) is one of the most frequent causes of cancer-related
death among women, which is due to the poor response to conventional therapy. There are …

Canine inflammatory mammary cancer (IMC) is a highly aggressive and lethal cancer in
dogs serving as a valuable animal model for its human counterpart, inflammatory breast …

Pancreatic cancer is a devastating disease with a high mortality rate and a lack of effective
therapies. The challenges associated with early detection and the highly aggressive nature …

Tumor neoantigens are widely used in cancer immunotherapy, and a growing body of
research suggests that microbes play an important role in these neoantigen-based …